All Type of News
Dispute mounts over Sanofi-Synthelabo's partnership with Zuellig
President Christian Stoeckling at Zuellig Pharma Korea said in its September 3 statement that Sanofi-Synthelabo Korea has decided to select Zuellig as one of the main outsourcing partners and from this September 1, Sa...
KFDA to upgrade GMP inspection system
Aiming to upgrade the nation's GMP inspection system to a level of advanced countries, the Korea Food and Administration said it signed a Memorandum of Understanding with Seoul National University that is responsible ...
Even combined prescription drugs require equivalency test.
The KFDA disclosed two revised drafts of regulations named "The Drug Equivalency Test Regulation" and "The Bio-Equivalency Test Standard" on Sept. 3, covering that even combined prescription drugs require the equivale...
New KFDA head emphasized registration system for competitiveness.
Chief commissioner Kim Chung-sook of KFDA stated that the pharmaceutical registration system should be improved to enhance the competitiveness of the pharmaceutical industry that had been adopted as one of the nationa...
Big foreign makers face heat from generics
Some of foreign-invested pharmaceutical firms, such as Pfizer Korea and Handok Pharm, face an aggressive assault as local firms look to steal market share by launching a number of amlodipine and glimepiride generics t...
87% of practitioners positive for prescribing generics
A survey has indicated that 9 out of 10 practitioners in Korea would positively consider the prescribing of generic drugs, particularly in the domestic antihypertensive and diabetic market.
A survey conducted by U...
130 billion won of amlodipine sales by domestic drug companies.
Amid a feverish promotional war on amlodipine markets among the domestic drug companies to preoccupy its shares, the 2005 sales targets estimated 130 billion won for 4 different amlodipine competitors, SK's Skad, Hanm...
Korea Green Cross Corporation renamed KGC holding company
The board of director at Korea Green Cross has decided to rename Korea Green Cross Corporation as KGC holding company, with the objective of developing as the country's first comprehensive, independent pharmaceutical ...
No safety problem on drugs containing poison and deleterious substances.
In responding to the recent controversy raised by the press over the safety problems on the non-prescription GI drug containing a poisonous and deleterious ingredient the MOHW confirmed no safety problems at all since...
Kim Jung-sook to head Korea Food and Drug AdministrationPresident Roh Moo-hyun on September 1st appointed senior researcher of the Korea Institute of Oriental Medicine Kim Jung Sook as a new commissioner of the Korea Food and Drug Ad...
|
